Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02716038
Title Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Columbia University
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.